|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.25 USD | -.--% |
|
-.--% | +1.96% |
Integrated BioPharma, Inc. reported earnings results for the first quarter ended September 30, 2021. For the first quarter, the company reported sales was USD 12.75 million compared to USD 15.17 million a year ago. Net income was USD 0.516 million compared to USD 1.04 million a year ago.
Basic earnings per share from continuing operations was USD 0.02 compared to USD 0.04 a year ago. Diluted earnings per share from continuing operations was USD 0.02 compared to USD 0.03 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +1.96% | 7.52M | |
| +45.82% | 754B | |
| +40.95% | 630B | |
| -6.16% | 352B | |
| +19.86% | 331B | |
| +9.32% | 298B | |
| +18.45% | 250B | |
| +11.88% | 217B | |
| -0.78% | 216B | |
| +5.90% | 164B |
INTEGRATED BIOPHARMA, INC. 
